Lowering homocysteine and modifying nutritional status with folic acid and vitamin B12in Indian patients of vascular disease

Journal of Clinical Biochemistry and Nutrition

Volumn 50, Issue 3, 2012, Pages 222-226

  Bhargava, Seema ^a   Ali, Arif ^b   Bhargava, Eishaan Kamta ^a   Manocha, Anjali ^a   Kankra, Mamta ^a   Das, Sabari ^a   Srivastava, Lalit Mohan ^a  

^a SIR GANGA RAM HOSPITAL   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Folate; Food fortification; Hyperhomocysteinemia; Vascular disease; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CYANOCOBALAMIN DEFICIENCY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; HUMAN; HYPERHOMOCYSTEINEMIA; INDIA; MAJOR CLINICAL STUDY; NUTRITIONAL STATUS; PERIPHERAL VASCULAR DISEASE; TREATMENT RESPONSE; VASCULAR DISEASE; VITAMIN BLOOD LEVEL;

EID: 84860732028     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.11-72     Document Type: Article

References (33)

1. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiological transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746-2753. (Pubitemid 33108145)
2. Chambers J, Obeid O, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000; 355 (9203): 523-527. (Pubitemid 30088671)
3. Ueland PM, Refsum H, Brattstrom L. Plasma homocysteine and cardiovascular disease. In: Francis RB Jr., ed. Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. New York: Marcel Dekker, 1992; 183-235.
4. Nygård O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study. JAMA 1995; 274: 1526-1533.
5. Stampfer MJ, Malinow MR. Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med 1995; 332: 328-329.
6. Ubbink JB, Delport R, Vermaak WJ. Plasma homocysteine concentration in population with a low coronary heart disease prevalence. J Nutr 1996; 126: S1254-S1257.
7. Miller A. The methionine-homocysteine cycle and its effects on cognitive diseases. Altern Med Rev 2003; 8: 7-19. (Pubitemid 36330564)
8. Brattström L, Lindgren A, Israelsson B, et al. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest 1992; 22: 214-221.
9. Andersson A, Brattström L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992; 22: 79-87.
10. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenburg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693-2698. (Pubitemid 23350966)
11. Brattström L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994; 236: 633-641.
12. Lindenbaum J, Rosenberg IH, Wilson PW, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994; 60: 2-11.
13. Jacobsen DW, Gatautis VJ, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem 1994; 40: 873-881. (Pubitemid 24166304)
14. Selhub J, Jacques PF, Bostom AG, et al. Relation between plasma homocysteine, vitamin status and extracranial carotid artery stenosis in the Framingham study population. J Nutr 1996; 126: S1258-S1265.
15. Kang SS, Wong PW, Norusis M. Homocysteinemia due to folate deficiency. Metabolism 1987; 36: 458-462. (Pubitemid 17072112)
16. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-1155.
17. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39: 1764-1779. (Pubitemid 23277003)
18. Stabler SP, Marcell PD, Podell ER, Allen RH, Savage D, Lindenbaum J. Elevation of total homocysteine in the serum of patients with cobalamine or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 1988; 81: 466-474. (Pubitemid 18075242)
19. Wilcken DE, Reddy SG, Gupta VJ. Homocysteinemia, ischaemic heart disease, and the carrier state for homocysteinuria. Metabolism 1983; 32: 363-370. (Pubitemid 13083592)
20. Brattström L, Israelsson B, Lindgärde F, Hultberg B. Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocysteinuria due to cystathionine-beta-synthase deficiency. Metabolism 1988; 37: 175-178. (Pubitemid 18055235)
21. Sauberlich HE, Kretsch MJ, Skala JH, Johnson HL, Taylor PC. Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr 1987; 46: 1016-1028. (Pubitemid 18032755)
22. Brattström LE, Hultberg BL, Hardebo JE. Folic acid responsive postmenopausal homocysteinemia. Metabolism 1985; 34: 1073-1077. (Pubitemid 16217689)
23. Brattström L, Israelsson B, Norving B, et al. Impaired homocysteine metabolism in early onset cerebral and peripheral occlusive arterial disease: effect of pyridoxine and folic acid treatment. Atherosclerosis 1990; 81: 51-60. (Pubitemid 20058208)
24. Ubbink JB, van der Merwe A, Vermaak WJ, Delport R. Hyperhomocysteinemia and the response to vitamin supplementation. Clin Investig 1993; 71: 993-998. (Pubitemid 23362465)
25. Dudman NPB, Wilcken DEL, Wang J, Lynch JF, Macey D, Lundberg P. Disordered methionine/homocysteine metabolism in premature vascular disease: its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb 1993; 13: 1253-1260. (Pubitemid 23271127)
26. Franken DG, Boers GH, Blom HJ, Trijbels FJ, Kloppenborg PW. Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb 1994; 14: 465-470.
27. Ubbink JB, Vermaak WFH, van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994; 124: 1927-1933. (Pubitemid 24334627)
28. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318: 1720-1728.
29. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency I: usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 1990; 34: 90-98. (Pubitemid 20180100)
30. Refsum H, Yajnik CS, Gadkari M, et al. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 2001; 74: 233-241. (Pubitemid 32702491)
31. Carmel R, Mallidi PV, Vinarskiy S, Brar S, Frouhar Z. Hyper homocysteinemia and cobalamin deficiency in young Asian Indians in the United States. Am J Hematol 2002; 70: 107-114.
32. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of homocysteine as a risk factor for vascular disease: probable benefits from increasing folic acid intakes. JAMA 1995; 274: 1049-1057.
33. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Indian Heart J 2000; 52: S18-S26.